{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:16:28Z","timestamp":1789982188767,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T00:00:00Z","timestamp":1373328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jclinepi.2013.03.020","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T01:16:09Z","timestamp":1373332569000},"page":"S51-S56","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S","title":["Approaches to inverse-probability-of-treatment\u2013weighted estimation with concurrent treatments"],"prefix":"10.1016","volume":"66","author":[{"given":"Alan R.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Alan","family":"Brookhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2013.03.020_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.jclinepi.2013.03.020_bib2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/1468-0262.00442","article-title":"Efficient estimation of average treatment effects using the estimated propensity score","volume":"71","author":"Hirano","year":"2003","journal-title":"Econometrica"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","article-title":"Marginal structural models as a tool for standardization","volume":"14","author":"Sato","year":"2003","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.jclinepi.2013.03.020_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jech.2004.029496","article-title":"Estimating causal effects from epidemiological data","volume":"60","author":"Hern\u00e1n","year":"2006","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/aje\/kwi106","article-title":"Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal anti-inflammatory drugs and short-term mortality in the elderly","volume":"161","author":"St\u00fcrmer","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.jclinepi.2013.03.020_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/0193841X08317586","article-title":"Weighting regressions by propensity scores","volume":"32","author":"Freedman","year":"2008","journal-title":"Eval Rev"},{"issue":"1","key":"10.1016\/j.jclinepi.2013.03.020_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1257\/jel.47.1.5","article-title":"Recent developments in the econometrics of program evaluation","volume":"47","author":"Imbens","year":"2009","journal-title":"J Econ Lit"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/pds.3297","article-title":"Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions","volume":"22","author":"Kilpatrick","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.jclinepi.2013.03.020_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000328037","article-title":"Renal anemia of inflammation: the name is self-explanatory","volume":"32","author":"Yilmaz","year":"2011","journal-title":"Blood Purif"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0272-6386(97)90192-X","article-title":"Iron management in end-stage renal disease","volume":"29","author":"Fishbane","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.jclinepi.2013.03.020_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrneph.2010.139","article-title":"Iron supplementation to treat anemia in patients with chronic kidney disease","volume":"6","author":"Besarab","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1525-139X.2006.00174.x","article-title":"Intravenous iron therapy in end-stage renal disease","volume":"19","author":"Brewster","year":"2006","journal-title":"Semin Dial"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib14","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/ndt\/15.11.1827","article-title":"Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration","volume":"15","author":"Parkkinen","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.jclinepi.2013.03.020_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2190001","article-title":"Oxygen toxicity, oxygen radicals, transition metals and disease","volume":"219","author":"Halliwell","year":"1984","journal-title":"Biochem J"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib16","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/ndt\/gfr711","article-title":"Effects of intravenous iron on mononuclear cells during the haemodialysis session","volume":"27","author":"Martin-Malo","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.nu.05.070185.002053","article-title":"Mechanisms and consequences of lipid peroxidation in biological systems","volume":"5","author":"Sevanian","year":"1985","journal-title":"Annu Rev Nutr"},{"issue":"5","key":"10.1016\/j.jclinepi.2013.03.020_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0891-5849(95)02173-6","article-title":"The role of oxidized lipoproteins in atherogenesis","volume":"20","author":"Berliner","year":"1996","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.jclinepi.2013.03.020_bib19","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib20","series-title":"USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","year":"2009"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib21","series-title":"Researcher's Guide to the USRDS Database: 2010 ADR Edition","year":"2011"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib22","series-title":"Moving the goalposts: addressing limited overlap in the estimation of average treatment effects by changing the estimand","author":"Crump","year":"2006"},{"issue":"1","key":"10.1016\/j.jclinepi.2013.03.020_bib23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2202\/1557-4679.1022","article-title":"Causal effect models for realistic individualized treatment and intention to treat rules","volume":"3","author":"van der Laan","year":"2007","journal-title":"Int J Biostat"},{"key":"10.1016\/j.jclinepi.2013.03.020_bib24","series-title":"Data-adaptive selection of the truncation level for inverse-probability-of-treatment-weighted estimators","author":"Bembom","year":"2008"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435613001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435613001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T14:26:25Z","timestamp":1539527185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435613001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0895435613001571"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2013.03.020","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}